Potential contributors to the lower LVMI values in this large trial might have been the different imaging technique, an earlier diagnosis of hypertension with more rigorous control of BP, and use of renin–angiotensin–aldosterone system inhibitors by more than 80% [13,14,62], as seems to have been the case in our series as well. The gene discussed is REN; the disease is Hypertension.